Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Altimmune, Inc. (ALT)
USD2.99
+0.06 (+2.05%)
US NASDAQ Healthcare Biotechnology
Address
910 Clopper Road 20878
Gaithersburg, MD, US
Gaithersburg, MD, US
CEO
Jerome Benedict Durso
Website
altimmune.com
IPO
2017-05-26
CIK 1326190 ISIN US02155H2004
Description
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted the Altimmune, Inc. moniker in September 2015. Established in 1997, the company maintains its corporate headquarters in Gaithersburg, Maryland.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.99
+0.06 (+2.05%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
0.23
Float Shares
87.56M
Free Float %
99.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.32% | +0.33% | -4.64% | -32.01% | -24.14% | -14.68% | -46.53% | -36.49% | -75.82% | -97.69% | -97.69% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
2.99
Low
2.50
-16.4%
Consensus
11.25
+276.3%
Median
11.25
+276.3%
High
20.00
+568.9%
DCF (Unlevered)
0.08
-97.3%
DCF (Levered)
0.09
-97.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
82% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 6 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | -1 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
2.50
-16.4%
|
| Last Quarter | 1 |
2.50
-16.4%
|
| Last Year | 2 |
11.25
+276.3%
|
| All Time | 8 |
23.81
+696.3%
|
Quality scores
Altman Z-Score
-0.21
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+105.0% ★ Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+25.4% Q1'26: +30.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-216,348.8%
-
EBIT margin Biotechnology: +0.0%-230,461.0%
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+24.1% Q1'26: +64.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.38× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 7 EPS Ana. |
Dec 2027 6 Rev. Ana. 7 EPS Ana. |
Dec 2028 9 Rev. Ana. 7 EPS Ana. |
Dec 2029 4 Rev. Ana. 2 EPS Ana. |
Dec 2030 4 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.64M
est: 22.50M (-52.7%)
|
5.23M
est: 13.50M (-61.3%)
|
41.5K
est: 9.63M (-99.6%)
|
10.33M
est: 11.15M (-7.3%)
|
5.80M
est: 5.98M (-2.9%)
|
8.19M
est: 7.69M (+6.4%)
|
4.41M
est: 1.18M (+274.0%)
|
-68.0K
est: 34.9K (-295.1%)
|
426.0K
est: 409.0K (+4.2%)
|
20.0K
est: 1.4K (+1,299.6%)
|
41.0K
est: 5.6K (+637.9%)
|
8.0K
8.0K – 8.0K
+44.0% YoY
|
25.73M
25.73M – 25.73M
+321,535.0% YoY
|
94.11M
94.11M – 94.11M
+265.8% YoY
|
68.17M
68.17M – 68.17M
-27.6% YoY
|
192.65M
192.65M – 192.65M
+182.6% YoY
|
| EBITDA |
-3.18M
est: -13.50M (+76.4%)
|
-10.91M
est: -8.10M (-34.7%)
|
-51.76M
est: -5.78M (-795.5%)
|
-44.72M
est: -6.69M (-568.6%)
|
-20.19M
est: -3.59M (-463.1%)
|
-38.10M
est: -64.27M (+40.7%)
|
-96.53M
est: -707.4K (-13,546.3%)
|
-84.41M
est: -93.65M (+9.9%)
|
-87.94M
est: -245.4K (-35,733.3%)
|
-94.81M
est: -857.00 (-11,063,143.9%)
|
-94.49M
est: -3.3K (-2,834,853.5%)
|
-4.8K
-4.8K – -4.8K
-44.0% YoY
|
-15.44M
-15.44M – -15.44M
-321,535.0% YoY
|
-56.47M
-56.47M – -56.47M
-265.8% YoY
|
-40.90M
-40.90M – -40.90M
+27.6% YoY
|
-115.59M
-115.59M – -115.59M
-182.6% YoY
|
| EBIT |
-856.6K
est: -13.50M (+93.7%)
|
-11.05M
est: -8.10M (-36.4%)
|
-51.90M
est: -5.78M (-797.9%)
|
-45.02M
est: -6.69M (-573.1%)
|
-20.58M
est: -3.59M (-473.9%)
|
-38.53M
est: -65.04M (+40.8%)
|
-97.09M
est: -707.4K (-13,624.2%)
|
-84.90M
est: -94.25M (+9.9%)
|
-88.41M
est: -245.4K (-35,927.7%)
|
-95.05M
est: -857.00 (-11,090,915.2%)
|
-94.49M
est: -3.3K (-2,834,853.5%)
|
-4.8K
-4.8K – -4.8K
-44.0% YoY
|
-15.44M
-15.44M – -15.44M
-321,535.0% YoY
|
-56.47M
-56.47M – -56.47M
-265.8% YoY
|
-40.90M
-40.90M – -40.90M
+27.6% YoY
|
-115.59M
-115.59M – -115.59M
-182.6% YoY
|
| Net Income |
-3.44M
est: -1.49B (+99.8%)
|
193.85M
est: -4.47B (+104.3%)
|
-46.43M
est: -5.86B (+99.2%)
|
-39.17M
est: -1.55B (+97.5%)
|
-20.52M
est: -107.93M (+81.0%)
|
-49.04M
est: -58.66M (+16.4%)
|
-97.09M
est: -171.35M (+43.3%)
|
-84.71M
est: -81.31M (-4.2%)
|
-88.45M
est: -140.67M (+37.1%)
|
-95.06M
est: -117.95M (+19.4%)
|
-88.09M
est: -88.09M (+0.0%)
|
-97.03M
-114.54M – -79.51M
-10.1% YoY
|
-154.07M
-156.61M – -68.58M
-58.8% YoY
|
-102.62M
-314.32M – 486.79M
+33.4% YoY
|
-96.47M
-96.47M – -96.47M
+6.0% YoY
|
-47.36M
-47.36M – -47.36M
+50.9% YoY
|
| SGA |
6.22M
est: 3.80B (-99.8%)
|
11.52M
est: 2.28B (-99.5%)
|
8.46M
est: 1.63B (-99.5%)
|
9.77M
est: 1.88B (-99.5%)
|
8.50M
est: 1.01B (-99.2%)
|
13.21M
est: 1.30B (-99.0%)
|
15.41M
est: 199.02M (-92.3%)
|
17.13M
est: 5.88M (+191.2%)
|
18.14M
est: 124.97M (-85.5%)
|
20.97M
est: 436.6K (+4,701.9%)
|
28.10M
est: 1.70M (+1,555.2%)
|
2.44M
2.44M – 2.44M
+44.0% YoY
|
7.86B
7.86B – 7.86B
+321,535.1% YoY
|
28.76B
28.76B – 28.76B
+265.8% YoY
|
20.83B
20.83B – 20.83B
-27.6% YoY
|
58.86B
58.86B – 58.86B
+182.6% YoY
|
| EPS |
-16.13
est: -21.00 (+23.2%)
|
-49.80
est: -63.00 (+21.0%)
|
-108.77
est: -82.50 (-31.8%)
|
-13.98
est: -21.87 (+36.1%)
|
-1.56
est: -1.52 (-2.6%)
|
-1.91
est: -2.56 (+25.5%)
|
-2.35
est: -2.41 (+2.6%)
|
-1.81
est: -2.00 (+9.7%)
|
-1.66
est: -1.60 (-4.0%)
|
-1.34
est: -1.35 (+0.6%)
|
-1.00
est: -0.98 (-2.4%)
|
-1.07
-1.30 – -0.90
-10.1% YoY
|
-1.16
-1.78 – -0.78
-8.1% YoY
|
-1.15
-3.57 – 5.53
+0.8% YoY
|
-1.10
-1.10 – -1.10
+5.0% YoY
|
-0.54
-0.54 – -0.54
+50.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-67.84M
OE per share TTM
-0.79
Owner's Yield
-21.89%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
40.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
64
Total invested
59.62M
Insider transactions (90d)
8
Beneficial owners (>5%)
45
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Inc. | 4.18M | 7.79% | — | 4.18M | — | 4.18M | HC | England and Wales | 2024-02-14 | ↗ |
| 2 | (1) BlackRock, Inc. | 4.04M | 7.50% | 3.98M | — | 4.04M | — | HC | Delaware | 2024-01-26 | ↗ |
| 3 | TAM UK Holdings Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 4 | TAM UK International Holdings Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 5 | TC Financing Ltd | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 6 | Threadneedle Asset Management Holdings Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 7 | Threadneedle Asset Management Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 8 | Threadneedle Holdings Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 9 | Threadneedle Investment Services Limited | 4.01M | 7.47% | — | 4.01M | — | 4.01M | FI | England and Wales | 2024-02-14 | ↗ |
| 10 | EIN #00-0000000 | 3.83M | 7.80% | — | 3.83M | — | 3.83M | IA, HC | Jersey, Channel Islands | 2023-02-13 | ↗ |
| 11 | SSGA FUNDS MANAGEMENT, INC. | 3.82M | 9.61% | — | 3.81M | — | 3.82M | IA | BOSTON, MASSACHUSETTS | 2022-02-11 | ↗ |
| 12 | (1)Names of reporting persons. BlackRock, Inc. | 2.96M | 7.40% | 2.91M | — | 2.96M | — | HC | Delaware | 2022-02-04 | ↗ |
| 13 | Israel A. Englander | 2.91M | 5.40% | — | 2.91M | — | 2.91M | IN | Delaware | 2024-03-05 | ↗ |
| 14 | Millennium Group Management LLC | 2.91M | 5.40% | — | 2.91M | — | 2.91M | OO | Delaware | 2024-03-05 | ↗ |
| 15 | Millennium Management LLC | 2.91M | 5.40% | — | 2.91M | — | 2.91M | OO | Delaware | 2024-03-05 | ↗ |
| 16 | Avidity Capital Partners (GP) LLC | 2.77M | 7.00% | — | 2.77M | — | 2.77M | OO | Delaware | 2022-01-03 | ↗ |
| 17 | Avidity Capital Partners Fund (GP) LP | 2.77M | 7.00% | — | 2.77M | — | 2.77M | PN, OO | Delaware | 2022-01-03 | ↗ |
| 18 | Avidity Partners Management (GP) LLC | 2.77M | 7.00% | — | 2.77M | — | 2.77M | OO | Delaware | 2022-01-03 | ↗ |
| 19 | Avidity Partners Management LP | 2.77M | 7.00% | — | 2.77M | — | 2.77M | IA, PN | Delaware | 2022-01-03 | ↗ |
| 20 | David Witzke | 2.77M | 7.00% | — | 2.77M | — | 2.77M | IN | Delaware | 2022-01-03 | ↗ |
| 21 | Michael Gregory | 2.77M | 7.00% | — | 2.77M | — | 2.77M | IN | Delaware | 2022-01-03 | ↗ |
| 22 | Bihua Chen | 2.65M | 6.13% | — | 2.65M | — | — | IN | Delaware | 2022-07-07 | ↗ |
| 23 | Cormorant Asset Management, LP | 2.65M | 6.13% | — | 2.65M | — | — | PN | Delaware | 2022-07-07 | ↗ |
| 24 | Cormorant Global Healthcare GP, LLC | 2.65M | 6.13% | — | 2.65M | — | — | OO | Delaware | 2022-07-07 | ↗ |
| 25 | Cormorant Global Healthcare Master Fund, LP | 2.65M | 6.13% | — | 2.65M | — | — | PN | Delaware | 2022-07-07 | ↗ |
| 26 | The Vanguard Group - 23-1945930 | 2.53M | 5.15% | — | 12.6K | — | — | IA | Pennsylvania | 2023-02-09 | ↗ |
| 27 | TIAACREF Investment Management, LLC | 2.21M | 5.76% | 2.21M | — | 2.21M | — | IA | Delaware | 2022-02-11 | ↗ |
| 28 | Avidity Master Fund LP | 2.20M | 5.50% | — | 2.20M | — | 2.20M | PN, OO | Delaware | 2022-01-03 | ↗ |
| 29 | Baker Bros. Advisors (GP) LLC | 1.94M | 4.80% | 1.94M | — | 1.94M | — | HC, OO | Delaware | 2022-02-14 | ↗ |
| 30 | Baker Bros. Advisors LP | 1.94M | 4.80% | 1.94M | — | 1.94M | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 31 | Felix J. Baker | 1.94M | 4.80% | 1.94M | — | 1.94M | — | HC, IN | United States | 2022-02-14 | ↗ |
| 32 | Julian C. Baker | 1.94M | 4.80% | 1.94M | — | 1.94M | — | HC, IN | United States | 2022-02-14 | ↗ |
| 33 | Koh, Bong | 1.76M | 4.20% | — | 1.76M | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 34 | Shah, Nimish | 1.76M | 4.20% | — | 1.76M | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 35 | VHCP Co-Investment Holdings II, LLC | 1.76M | 4.20% | — | 1.76M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 36 | VHCP Co-Investment Holdings III, LLC | 1.76M | 4.20% | — | 1.76M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 37 | VHCP Management II, LLC | 1.76M | 4.20% | — | 1.76M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 38 | VHCP Management III, LLC | 1.76M | 4.20% | — | 1.76M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 39 | Venrock Healthcare Capital Partners II, L.P. | 1.76M | 4.20% | — | 1.76M | — | — | PN | Delaware | 2022-02-14 | ↗ |
| 40 | Venrock Healthcare Capital Partners III, L.P. | 1.76M | 4.20% | — | 1.76M | — | — | PN | Delaware | 2022-02-14 | ↗ |
| 41 | Sphera Funds Management Ltd. | 1.24M | 3.13% | — | 1.24M | — | — | CO | Israel | 2022-02-14 | ↗ |
| 42 | Sphera Global Healthcare GP Ltd. | 1.24M | 3.13% | — | 1.24M | — | — | CO | Israel | 2022-02-14 | ↗ |
| 43 | Sphera Global Healthcare Management LP | 1.24M | 3.13% | — | 1.24M | — | — | CO | Israel | 2022-02-14 | ↗ |
| 44 | Sphera Healthcare US Inc. | 1.24M | 3.13% | — | 1.24M | — | — | CO | Israel | 2022-02-14 | ↗ |
| 45 | STATE STREET CORPORATION | 691.1K | 1.60% | — | 635.3K | — | 691.1K | HC | BOSTON, MASSACHUSETTS | 2022-04-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
64
-137 vs prev Q
New positions
11
Closed positions
131
Increased
42
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 100.0K +100.0K (+100.0%) | 361.00M +361.0M (+100.0%) | 0.11% +0.112 pp | 0.00% +0.001 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 9.70M +3.3M (+52.3%) | 35.03M +11.0M (+45.8%) | 10.85% +3.031 pp | 0.00% +0.000 pp | USD5.29 -31.8% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 9.49M +3.1M (+48.9%) | 34.26M +10.2M (+42.6%) | 10.61% +2.792 pp | 0.00% +0.000 pp | USD5.88 -38.6% | 29 qtrs — |
| 4 | STATE STREET CORP | 5.12M +1.5M (+42.2%) | 18.48M +4.9M (+36.1%) | 5.73% +1.306 pp | 0.00% +0.000 pp | USD7.35 -50.9% | 20 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.29M +275.0K (+13.6%) | 8.28M +670.7K (+8.8%) | 2.56% +0.088 pp | 0.00% +0.000 pp | USD6.17 -41.5% | 29 qtrs — |
| 6 | TANG CAPITAL MANAGEMENT LLC | 2.13M +— (+0.0%) | 7.69M -341.0K (-4.2%) | 2.38% -0.232 pp | 0.38% +0.071 pp | USD9.84 -63.3% | 19 qtrs — |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.77M +80.3K (+4.8%) | 6.38M +20.1K (+0.3%) | 1.98% -0.094 pp | 0.00% +0.000 pp | USD5.55 -35.0% | 28 qtrs — |
| 8 | MORGAN STANLEY | 1.36M -131.2K (-8.8%) | 4.91M -712.1K (-12.7%) | 1.52% -0.309 pp | 0.00% +0.000 pp | USD6.33 -43.0% | 30 qtrs — |
| 9 | GOLDMAN SACHS GROUP INC | 1.35M +787.0K (+140.0%) | 4.87M +2.8M (+129.8%) | 1.51% +0.819 pp | 0.00% +0.000 pp | USD5.54 -34.8% | 23 qtrs — |
| 10 | D. E. SHAW & CO., INC. | 1.34M +983.2K (+272.8%) | 4.85M +3.5M (+257.0%) | 1.50% +1.060 pp | 0.00% +0.002 pp | USD3.74 -3.5% | 22 qtrs — |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.27M -731.2K (-36.6%) | 4.57M -3.0M (-39.3%) | 1.42% -1.035 pp | 0.01% -0.005 pp | USD4.29 -15.9% | 7 qtrs — |
| 12 | NUVEEN, LLC | 1.24M +1.0M (+514.9%) | 4.49M +3.7M (+488.8%) | 1.39% +1.143 pp | 0.00% +0.001 pp | USD3.84 -6.0% | 4 qtrs — |
| 13 | KNOLL CAPITAL MANAGEMENT, LLC | 1.12M +— (+0.0%) | 4.05M -179.4K (-4.2%) | 1.25% -0.122 pp | 1.86% -0.409 pp | USD8.91 -59.5% | 21 qtrs — |
| 14 | MARSHALL WACE, LLP | 922.8K +922.8K (+100.0%) | 3.33M +3.3M (+100.0%) | 1.03% +1.032 pp | 0.00% +0.003 pp | USD3.61 +0.0% | 5 qtrs — |
| 15 | TWO SIGMA ADVISERS, LP | 793.9K -634.5K (-44.4%) | 2.87M -2.5M (-46.8%) | 0.89% -0.865 pp | 0.01% -0.005 pp | USD3.93 -8.1% | 7 qtrs — |
| 16 | NORTHERN TRUST CORP | 716.0K +59.0K (+9.0%) | 2.58M +107.8K (+4.4%) | 0.80% -0.006 pp | 0.00% +0.000 pp | USD6.14 -41.2% | 26 qtrs — |
| 17 | FMR LLC | 564.1K +119.0K (+26.7%) | 2.04M +358.2K (+21.3%) | 0.63% +0.085 pp | 0.00% +0.000 pp | USD3.88 -7.0% | 16 qtrs — |
| 18 | DIADEMA PARTNERS LP | 491.8K +28.8K (+6.2%) | 1.78M +29.9K (+1.7%) | 0.55% -0.018 pp | 0.31% -0.141 pp | USD4.54 -20.5% | 5 qtrs — |
| 19 | SCHRODER INVESTMENT MANAGEMENT GROUP | 469.0K +469.0K (+100.0%) | 1.69M +1.7M (+100.0%) | 0.52% +0.525 pp | 0.00% +0.001 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 20 | CITADEL ADVISORS LLC | 423.2K +53.5K (+14.5%) | 1.53M +134.0K (+9.6%) | 0.47% +0.020 pp | 0.00% +0.000 pp | USD6.66 -45.8% | 29 qtrs — |
| 21 | BARCLAYS PLC | 400.6K +244.9K (+157.2%) | 1.45M +489.9K (+51.2%) | 0.45% +0.257 pp | 0.00% +0.000 pp | USD4.57 -21.0% | 23 qtrs — |
| 22 | SOVIERO ASSET MANAGEMENT, LP | 400.0K +400.0K (+100.0%) | 1.44M +1.4M (+100.0%) | 0.45% +0.447 pp | 0.69% +0.692 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 23 | BANK OF AMERICA CORP /DE/ | 383.8K +63.3K (+19.8%) | 1.39M +177.4K (+14.7%) | 0.43% +0.036 pp | 0.00% +0.000 pp | USD5.21 -30.7% | 20 qtrs — |
| 24 | BEIRNE WEALTH CONSULTING SERVICES, LLC | 376.5K -34.0K (-8.3%) | 1.36M -188.4K (-12.2%) | 0.42% -0.083 pp | 0.39% +0.022 pp | USD8.38 -56.9% | 21 qtrs — |
| 25 | BANK OF NEW YORK MELLON CORP | 354.2K +12.2K (+3.6%) | 1.28M -10.6K (-0.8%) | 0.40% -0.024 pp | 0.00% +0.000 pp | USD5.01 -27.9% | 27 qtrs — |
| 26 | DIMENSIONAL FUND ADVISORS LP | 283.7K -14.1K (-4.7%) | 1.02M -98.6K (-8.8%) | 0.32% -0.048 pp | 0.00% +0.000 pp | USD7.26 -50.3% | 17 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 283.7K +79.2K (+38.7%) | 1.02M +253.3K (+32.9%) | 0.32% +0.066 pp | 0.00% +0.000 pp | USD5.01 -27.9% | 22 qtrs — |
| 28 | SCULPTOR CAPITAL LP | 276.7K +— (+0.0%) | 998.9K -44.3K (-4.2%) | 0.31% -0.030 pp | 0.01% -0.002 pp | USD4.18 -13.6% | 4 qtrs — |
| 29 | UBS GROUP AG | 275.5K -10.4K (-3.6%) | 994.6K -83.3K (-7.7%) | 0.31% -0.043 pp | 0.00% +0.000 pp | USD3.77 -4.2% | 2 qtrs — |
| 30 | BROWN WEALTH MANAGEMENT, LLC | 258.7K +25.0K (+10.7%) | 933.8K +52.9K (+6.0%) | 0.29% +0.003 pp | 0.25% -0.002 pp | USD5.48 -34.1% | 9 qtrs — |
| 31 | WELLINGTON MANAGEMENT GROUP LLP | 257.3K -7.5K (-2.8%) | 928.7K -69.6K (-7.0%) | 0.29% -0.037 pp | 0.00% +0.000 pp | USD8.13 -55.6% | 8 qtrs — |
| 32 | LMR PARTNERS LLP | 250.0K +— (+0.0%) | 902.5K -40.0K (-4.2%) | 0.28% -0.027 pp | 0.00% -0.003 pp | USD3.87 -6.7% | 3 qtrs — |
| 33 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 245.4K +26.1K (+11.9%) | 885.9K +59.1K (+7.1%) | 0.27% +0.005 pp | 0.00% +0.000 pp | USD4.84 -25.4% | 9 qtrs — |
| 34 | JUMP FINANCIAL, LLC | 242.0K +126.2K (+109.0%) | 873.7K +437.1K (+100.1%) | 0.27% +0.129 pp | 0.01% +0.006 pp | USD3.69 -2.2% | 2 qtrs — |
| 35 | INVESCO LTD. | 214.8K +52.9K (+32.7%) | 775.5K +165.0K (+27.0%) | 0.24% +0.042 pp | 0.00% +0.000 pp | USD5.20 -30.6% | 13 qtrs — |
| 36 | HENNION & WALSH ASSET MANAGEMENT, INC. | 214.6K +29.1K (+15.7%) | 774.8K +75.2K (+10.7%) | 0.24% +0.012 pp | 0.03% +0.001 pp | USD6.52 -44.6% | 7 qtrs — |
| 37 | MILLENNIUM MANAGEMENT LLC | 207.4K -160.2K (-43.6%) | 748.7K -637.1K (-46.0%) | 0.23% -0.219 pp | 0.00% 0.000 pp | USD4.17 -13.4% | 23 qtrs — |
| 38 | RAFFERTY ASSET MANAGEMENT, LLC | 195.8K +39.6K (+25.3%) | 706.7K +117.9K (+20.0%) | 0.22% +0.027 pp | 0.00% +0.001 pp | USD7.08 -49.0% | 8 qtrs — |
| 39 | COMMONWEALTH EQUITY SERVICES, LLC | 181.5K +7.4K (+4.2%) | 655.2K -850.0 (-0.1%) | 0.20% -0.011 pp | 0.00% +0.000 pp | USD6.70 -46.1% | 8 qtrs — |
| 40 | BNP PARIBAS ARBITRAGE, SNC | 177.3K +102.8K (+137.9%) | 640.1K +359.1K (+127.8%) | 0.20% +0.107 pp | 0.00% +0.000 pp | USD3.77 -4.2% | 20 qtrs — |
| 41 | IMC-CHICAGO, LLC | 173.1K +57.8K (+50.1%) | 625.0K +190.1K (+43.7%) | 0.19% +0.052 pp | 0.00% +0.000 pp | USD5.29 -31.8% | 9 qtrs — |
| 42 | GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 172.6K +172.6K (+100.0%) | 622.9K +622.9K (+100.0%) | 0.19% +0.193 pp | 0.00% +0.002 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 43 | JANE STREET GROUP, LLC | 159.8K +91.1K (+132.6%) | 576.9K +317.9K (+122.7%) | 0.18% +0.094 pp | 0.00% +0.000 pp | USD4.37 -17.4% | 6 qtrs — |
| 44 | DCF ADVISERS, LLC | 158.0K +158.0K (+100.0%) | 570.4K +570.4K (+100.0%) | 0.18% +0.177 pp | 0.15% +0.153 pp | USD3.61 +0.0% | 14 qtrs — |
| 45 | JEFFERIES FINANCIAL GROUP INC. | 157.8K +107.8K (+215.6%) | 569.7K +381.2K (+202.2%) | 0.18% +0.115 pp | 0.00% +0.002 pp | USD4.21 -14.3% | 9 qtrs — |
| 46 | LOS ANGELES CAPITAL MANAGEMENT LLC | 128.5K +128.5K (+100.0%) | 523.1K +523.1K (+100.0%) | 0.14% +0.144 pp | 0.00% +0.002 pp | USD3.61 +0.0% | 7 qtrs — |
| 47 | WELLS FARGO & COMPANY/MN | 141.3K +48.4K (+52.1%) | 510.0K +159.8K (+45.6%) | 0.16% +0.044 pp | 0.00% +0.000 pp | USD5.29 -31.8% | 23 qtrs — |
| 48 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 135.2K -50.1K (-27.0%) | 488.0K -210.3K (-30.1%) | 0.15% -0.076 pp | 0.01% -0.004 pp | USD3.82 -5.5% | 3 qtrs — |
| 49 | HSBC HOLDINGS PLC | 132.2K +59.1K (+80.8%) | 474.0K +202.0K (+74.3%) | 0.15% +0.058 pp | 0.00% +0.000 pp | USD4.28 -15.7% | 4 qtrs — |
| 50 | JACOBS LEVY EQUITY MANAGEMENT, INC | 124.8K +124.8K (+100.0%) | 450.6K +450.6K (+100.0%) | 0.14% +0.140 pp | 0.00% +0.002 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 51 | STIFEL FINANCIAL CORP | 123.4K +63.0K (+104.3%) | 445.5K +217.8K (+95.6%) | 0.14% +0.064 pp | 0.00% +0.000 pp | USD4.24 -14.9% | 7 qtrs — |
| 52 | RHUMBLINE ADVISERS | 121.5K -9.2K (-7.1%) | 438.7K -54.2K (-11.0%) | 0.14% -0.025 pp | 0.00% +0.000 pp | USD4.64 -22.2% | 11 qtrs — |
| 53 | BAIRD FINANCIAL GROUP, INC. | 119.4K +— (+0.0%) | 431.2K -19.1K (-4.2%) | 0.13% -0.013 pp | 0.00% 0.000 pp | USD5.48 -34.1% | 5 qtrs — |
| 54 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 114.1K -108.8K (-48.8%) | 412.0K -428.5K (-51.0%) | 0.13% -0.146 pp | 0.00% +0.001 pp | USD4.19 -13.8% | 7 qtrs — |
| 55 | WEALTH EFFECTS LLC | 111.8K +51.9K (+86.7%) | 403.4K +177.8K (+78.8%) | 0.13% +0.052 pp | 0.13% +0.054 pp | USD4.97 -27.4% | 8 qtrs — |
| 56 | JPMORGAN CHASE & CO | 104.5K +5.3K (+5.4%) | 377.4K +3.4K (+0.9%) | 0.12% -0.005 pp | 0.00% +0.000 pp | USD7.53 -52.1% | 19 qtrs — |
| 57 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 103.5K +— (+0.0%) | 373.6K -16.6K (-4.2%) | 0.12% -0.011 pp | 0.00% +0.000 pp | USD5.35 -32.5% | 16 qtrs — |
| 58 | SUMMIT FINANCIAL WEALTH ADVISORS, LLC | 103.3K +7.0K (+7.3%) | 372.9K +235.0 (+0.1%) | 0.12% -0.003 pp | 0.05% -0.004 pp | USD6.38 -43.4% | 7 qtrs — |
| 59 | JANNEY MONTGOMERY SCOTT LLC | 102.6K +44.1K (+75.2%) | 370.0K +149.0K (+67.4%) | 0.11% +0.043 pp | 0.00% +0.000 pp | USD3.70 -2.4% | 2 qtrs — |
| 60 | WALLEYE TRADING LLC | 95.8K +87.6K (+1,068.3%) | 345.8K +314.9K (+1,018.7%) | 0.11% +0.097 pp | 0.00% +0.000 pp | USD3.63 -0.6% | 5 qtrs — |
| 61 | ENGINEERS GATE MANAGER LP | 87.3K +46.2K (+112.6%) | 315.0K +160.3K (+103.6%) | 0.10% +0.047 pp | 0.00% +0.002 pp | USD3.69 -2.2% | 2 qtrs — |
| 62 | ALPS ADVISORS INC | 85.7K +85.7K (+100.0%) | 309.3K +309.3K (+100.0%) | 0.10% +0.096 pp | 0.00% +0.002 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 63 | DEUTSCHE BANK AG\ | 79.9K +3.0K (+4.0%) | 288.6K -1.3K (-0.4%) | 0.09% -0.005 pp | 0.00% +0.000 pp | USD6.43 -43.9% | 10 qtrs — |
| 64 | PEAK6 LLC | 78.0K -69.0K (-46.9%) | 281.6K -272.6K (-49.2%) | 0.09% -0.093 pp | 0.00% 0.000 pp | USD3.79 -4.7% | 5 qtrs — |
| 65 | CAPTION MANAGEMENT, LLC | 74.4K -55.6K (-42.7%) | 268.7K -221.4K (-45.2%) | 0.08% -0.076 pp | 0.00% -0.002 pp | USD3.91 -7.7% | 4 qtrs — |
| 66 | AMERIPRISE FINANCIAL INC | 73.8K -474.0 (-0.6%) | 266.6K -13.6K (-4.9%) | 0.08% -0.009 pp | 0.00% +0.000 pp | USD8.39 -57.0% | 13 qtrs — |
| 67 | PROFUND ADVISORS LLC | 72.3K +38.6K (+114.5%) | 261.0K +133.9K (+105.4%) | 0.08% +0.040 pp | 0.01% +0.004 pp | USD5.62 -35.8% | 8 qtrs — |
| 68 | ALLIANCEBERNSTEIN L.P. | 71.8K +— (+0.0%) | 259.1K -11.5K (-4.2%) | 0.08% -0.008 pp | 0.00% +0.000 pp | USD5.64 -36.0% | 11 qtrs — |
| 69 | VERITION FUND MANAGEMENT LLC | 69.5K +38.3K (+123.0%) | 250.8K +133.4K (+113.5%) | 0.08% +0.040 pp | 0.00% +0.001 pp | USD3.73 -3.2% | 3 qtrs — |
| 70 | WALLEYE CAPITAL LLC | 64.4K -24.0K (-27.1%) | 232.5K -100.8K (-30.2%) | 0.07% -0.037 pp | 0.00% -0.001 pp | USD3.80 -5.0% | 8 qtrs — |
| 71 | BALYASNY ASSET MANAGEMENT L.P. | 60.1K +60.1K (+100.0%) | 217.0K +217.0K (+100.0%) | 0.07% +0.067 pp | 0.00% +0.000 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 72 | VIRTU FINANCIAL LLC | 58.5K +10.4K (+21.7%) | 211.0K +30.0K (+16.6%) | 0.07% +0.006 pp | 0.01% -0.002 pp | USD3.82 -5.5% | 6 qtrs — |
| 73 | BLAIR WILLIAM & CO/IL | 56.4K +56.4K (+100.0%) | 203.7K +203.7K (+100.0%) | 0.06% +0.063 pp | 0.00% +0.001 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 74 | RAYMOND JAMES FINANCIAL INC | 55.9K +28.2K (+101.9%) | 201.7K +97.3K (+93.3%) | 0.06% +0.029 pp | 0.00% +0.000 pp | USD4.52 -20.1% | 5 qtrs — |
| 75 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 52.6K +6.7K (+14.5%) | 189.8K +16.5K (+9.5%) | 0.06% +0.002 pp | 0.00% +0.000 pp | USD6.48 -44.3% | 7 qtrs — |
| 76 | INTECH INVESTMENT MANAGEMENT LLC | 52.6K +13.9K (+36.0%) | 189.7K +44.1K (+30.2%) | 0.06% +0.011 pp | 0.00% +0.000 pp | USD4.54 -20.5% | 6 qtrs — |
| 77 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50.6K +— (+0.0%) | 182.7K -8.1K (-4.2%) | 0.06% -0.006 pp | 0.00% 0.000 pp | USD3.77 -4.2% | 2 qtrs — |
| 78 | VIRTUS INVESTMENT ADVISERS, INC. | 50.5K +34.6K (+217.2%) | 182.2K +122.2K (+203.8%) | 0.06% +0.037 pp | 0.05% +0.032 pp | USD3.98 -9.3% | 4 qtrs — |
| 79 | PRICE T ROWE ASSOCIATES INC /MD/ | 49.9K +8.4K (+20.2%) | 181.0K +24.0K (+15.3%) | 0.06% +0.005 pp | 0.00% +0.000 pp | USD6.78 -46.8% | 22 qtrs — |
| 80 | LPL FINANCIAL LLC | 48.6K -12.9K (-21.0%) | 175.5K -56.4K (-24.3%) | 0.05% -0.021 pp | 0.00% +0.000 pp | USD9.03 -60.0% | 9 qtrs — |
| 81 | VOLEON CAPITAL MANAGEMENT LP | 47.1K +47.1K (+100.0%) | 169.9K +169.9K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.004 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 82 | CREATIVE PLANNING | 46.9K +10.5K (+28.9%) | 169.3K +32.1K (+23.4%) | 0.05% +0.008 pp | 0.00% +0.000 pp | USD6.46 -44.1% | 9 qtrs — |
| 83 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 43.2K +43.1K (+79,838.9%) | 155.8K +155.6K (+76,288.7%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD3.61 +0.0% | 2 qtrs — |
| 84 | METLIFE INVESTMENT MANAGEMENT, LLC | 38.2K -6.3K (-14.2%) | 137.9K -30.0K (-17.9%) | 0.04% -0.012 pp | 0.00% 0.000 pp | USD5.03 -28.2% | 11 qtrs — |
| 85 | KINGSWOOD WEALTH ADVISORS, LLC | 36.0K +20.6K (+133.8%) | 130.0K +71.9K (+123.8%) | 0.04% +0.021 pp | 0.01% +0.003 pp | USD3.71 -2.7% | 3 qtrs — |
| 86 | ACADIAN ASSET MANAGEMENT LLC | 35.7K +35.7K (+100.0%) | 128.0K +128.0K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.000 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 87 | KOVACK ADVISORS, INC. | 35.2K +35.2K (+100.0%) | 127.1K +127.1K (+100.0%) | 0.04% +0.039 pp | 0.01% +0.006 pp | USD3.61 +0.0% | 1 qtrs NEW |
| 88 | SQUAREPOINT OPS LLC | 34.9K -549.7K (-94.0%) | 126.2K -2.1M (-94.3%) | 0.04% -0.679 pp | 0.00% -0.002 pp | USD3.77 -4.2% | 12 qtrs — |
| 89 | MML INVESTORS SERVICES, LLC | 34.6K +— (+0.0%) | 124.7K -5.5K (-4.2%) | 0.04% -0.004 pp | 0.00% +0.000 pp | USD8.37 -56.9% | 20 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 72 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.72% | 414.0K | 0.65% |
| 2 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.50% | 109.7K | 0.20% |
| 3 | ALPS Medical Breakthroughs ETF SBIO | 0.30% | 647.7K | 0.50% |
| 4 | Global X - S&P Biotech ETF CURE.AX | 0.23% | 82.4K | 0.45% |
| 5 | State Street SPDR S&P Biotech ETF XBI | 0.23% | 24.76M | 0.35% |
| 6 | iShares Micro-Cap ETF IWC | 0.14% | 2.04M | 0.60% |
| 7 | Fidelity Enhanced Small Cap ETF FESM | 0.05% | 2.72M | 0.28% |
| 8 | Pacer WealthShield ETF PWS | 0.05% | 11.5K | 0.60% |
| 9 | iShares Biotechnology ETF IBB | 0.04% | 4.03M | 0.44% |
| 10 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.04% | 188.9K | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
11
Sells
0
Shares acquired
424.6K
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+424,600
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | Schafer Klaus | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | SAYARE MITCHEL | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | Pisano Wayne | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | Lawver Teri L | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | Jorkasky Diane | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | Hodges Philip | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-05-01 | GILL JOHN | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 2.82 | 137.6K | 48,800 | D | ↗ |
| 2026-04-06 | GILL JOHN | Director | P-Purchase | A | Common Stock, par value $0.0001 | 9,200 | 3.41 | 31.3K | 21,700 | D | ↗ |
| 2026-04-01 | WEAVER GREGORY L | Officer | P-Purchase | A | Common Stock, par value $0.0001 | 10,000 | 3.15 | 31.5K | 38,078 | D | ↗ |
| 2026-04-01 | Durso Jerome Benedict | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 | 15,000 | 3.14 | 47.1K | 47,500 | D | ↗ |
| 2026-03-06 | WEAVER GREGORY L | Officer | P-Purchase | A | Common Stock, par value $0.0001 | 5,000 | 3.54 | 17.7K | 28,078 | D | ↗ |
| 2026-03-06 | Durso Jerome Benedict | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 | 20,000 | 3.54 | 70.8K | 32,500 | D | ↗ |
| 2026-02-26 | WEAVER GREGORY L | Officer | A-Award | A | Restricted Stock Units | 111,000 | 0.00 | — | 111,000 | D | ↗ |
| 2026-02-26 | Roberts M Scot | Officer | A-Award | A | Restricted Stock Units | 95,430 | 0.00 | — | 95,430 | D | ↗ |
| 2026-02-02 | Roberts M Scot | Officer | M-Exempt | D | Restricted Stock Units | 7,775 | 0.00 | — | 0 | D | ↗ |
| 2026-01-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 5,567 | 3.07 | 17.1K | 107,378 | D | ↗ |
| 2026-01-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 4,571 | 3.07 | 14.0K | 70,107 | D | ↗ |
| 2026-01-31 | Garg Vipin K | Director | A-Award | A | Common Stock, par value $0.0001 | 6,926 | 3.07 | 21.3K | 424,519 | D | ↗ |
| 2026-01-30 | Roberts M Scot | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 9,275 | 0.00 | — | 104,670 | D | ↗ |
| 2026-01-30 | Garg Vipin K | Director | M-Exempt | A | Common Stock, par value $0.0001 | 26,775 | 0.00 | — | 429,225 | D | ↗ |
| 2026-01-27 | Roberts M Scot | Officer | F-InKind | D | Common Stock, par value $0.0001 | 4,748 | 6.18 | 29.3K | 95,395 | D | ↗ |
| 2026-01-27 | Jordt Raymond M | Officer | M-Exempt | D | Restricted Stock Units | 15,850 | 0.00 | — | 47,550 | D | ↗ |
| 2026-01-27 | Garg Vipin K | Director | M-Exempt | D | Restricted Stock Units | 41,200 | 0.00 | — | 123,600 | D | ↗ |
| 2026-01-25 | Roberts M Scot | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 14,600 | 0.00 | — | 88,666 | D | ↗ |
| 2026-01-25 | Jordt Raymond M | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 14,600 | 0.00 | — | 57,770 | D | ↗ |
| 2026-01-25 | Garg Vipin K | Director | M-Exempt | A | Common Stock, par value $0.0001 | 42,050 | 0.00 | — | 397,132 | D | ↗ |
| 2026-01-08 | Pisano Wayne | Director | P-Purchase | A | Common Stock, par value $0.0001 | 5,000 | 4.08 | 20.4K | 13,498 | D | ↗ |
| 2026-01-05 | Sohn Catherine A. | Director | P-Purchase | A | Common Stock, par value $0.0001 | 500 | 4.24 | 2.1K | 1,500 | D | ↗ |
| 2026-01-01 | Jordt Raymond M | Officer | M-Exempt | D | Restricted Stock Units | 9,375 | 0.00 | — | 9,375 | D | ↗ |
| 2025-12-29 | Jorkasky Diane | Director | P-Purchase | A | Common Stock, par value $0.0001 | 527 | 3.80 | 2.0K | 527 | D | ↗ |
| 2025-12-23 | GILL JOHN | Director | P-Purchase | A | Common Stock, par value $0.0001 | 12,500 | 4.10 | 51.3K | 12,500 | D | ↗ |
| 2025-12-22 | Durso Jerome Benedict | Director | P-Purchase | A | Common Stock, par value $0.0001 | 12,500 | 4.13 | 51.6K | 12,500 | D | ↗ |
| 2025-12-01 | Durso Jerome Benedict | Director / Officer | A-Award | A | Stock Options (option to buy) | 1,824,400 | 4.93 | 8.99M | 1,824,400 | D | ↗ |
| 2025-11-11 | WEAVER GREGORY L | Officer | M-Exempt | D | Restricted Stock Units | 18,750 | 0.00 | — | 56,250 | D | ↗ |
| 2025-10-01 | WEAVER GREGORY L | Officer | A-Award | A | Stock Options (option to buy) | 166,800 | 3.87 | 645.5K | 166,800 | D | ↗ |
| 2025-10-01 | Arbet-Engels Christophe | Officer | A-Award | A | Stock Options (option to buy) | 450,000 | 3.87 | 1.74M | 450,000 | D | ↗ |
| 2025-09-25 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Schafer Klaus | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | SAYARE MITCHEL | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Pisano Wayne | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Lawver Teri L | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Jorkasky Diane | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Hodges Philip | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | GILL JOHN | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-25 | Durso Jerome Benedict | Director | A-Award | A | Stock Options (option to buy) | 48,800 | 3.92 | 191.3K | 48,800 | D | ↗ |
| 2025-09-16 | Richardson Linda M | Officer | A-Award | A | Stock Options (option to buy) | 278,000 | 3.63 | 1.01M | 278,000 | D | ↗ |
| 2025-07-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 846 | 3.14 | 2.7K | 74,066 | D | ↗ |
| 2025-07-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,368 | 3.14 | 4.3K | 36,270 | D | ↗ |
| 2025-07-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 2,018 | 3.14 | 6.3K | 16,087 | D | ↗ |
| 2025-03-17 | Sohn Catherine A. | Director | P-Purchase | A | Common Stock, par value $0.0001 | 1,000 | 5.78 | 5.8K | 1,000 | D | ↗ |
| 2025-03-13 | WEAVER GREGORY L | Officer | P-Purchase | A | Common Stock, par value $0.0001 | 10,000 | 5.20 | 52.0K | 10,000 | D | ↗ |
| 2025-03-07 | Harris Matthew Scott | Officer | G-Gift | D | Common Stock, par value $0.0001 | 67,787 | 0.00 | — | 14,069 | D | ↗ |
| 2025-02-24 | Lawver Teri L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-24 | Durso Jerome Benedict | Director | A-Award | A | Stock Options (option to buy) | 69,800 | 6.11 | 426.5K | 69,800 | D | ↗ |
| 2025-02-06 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 18,600 | 6.91 | 128.5K | 18,600 | D | ↗ |
| 2025-02-02 | Roberts M Scot | Officer | M-Exempt | A | Restricted Stock Units | 7,775 | 0.00 | — | 7,775 | D | ↗ |
| 2025-02-02 | Harris Matthew Scott | Officer | M-Exempt | A | Restricted Stock Units | 7,775 | 0.00 | — | 7,775 | D | ↗ |
| 2025-02-02 | Garg Vipin K | Director / Officer | M-Exempt | A | Common Stock, par value $0.0001 | 18,950 | 0.00 | — | 363,364 | D | ↗ |
| 2025-02-01 | Roberts M Scot | Officer | M-Exempt | A | Restricted Stock Units | 6,166 | 0.00 | — | 0 | D | ↗ |
| 2025-02-01 | Harris Matthew Scott | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 6,166 | 0.00 | — | 78,898 | D | ↗ |
| 2025-02-01 | Garg Vipin K | Director / Officer | M-Exempt | A | Restricted Stock Units | 16,545 | 0.00 | — | 0 | D | ↗ |
| 2025-01-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 3,184 | 5.18 | 16.5K | 63,396 | D | ↗ |
| 2025-01-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 2,614 | 5.18 | 13.5K | 34,902 | D | ↗ |
| 2025-01-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,905 | 5.18 | 9.9K | 72,732 | D | ↗ |
| 2025-01-31 | Garg Vipin K | Director / Officer | A-Award | A | Common Stock, par value $0.0001 | 4,105 | 5.18 | 21.3K | 335,100 | D | ↗ |
| 2025-01-30 | Roberts M Scot | Officer | M-Exempt | A | Restricted Stock Units | 9,275 | 0.00 | — | 18,550 | D | ↗ |
| 2025-01-30 | Harris Matthew Scott | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 9,275 | 0.00 | — | 74,000 | D | ↗ |
| 2025-01-30 | Garg Vipin K | Director / Officer | M-Exempt | A | Common Stock, par value $0.0001 | 26,775 | 0.00 | — | 342,696 | D | ↗ |
| 2025-01-27 | Roberts M Scot | Officer | A-Award | A | Restricted Stock Units | 63,400 | 0.00 | — | 63,400 | D | ↗ |
| 2025-01-27 | Jordt Raymond M | Officer | A-Award | A | Restricted Stock Units | 63,400 | 0.00 | — | 63,400 | D | ↗ |
| 2025-01-27 | Harris Matthew Scott | Officer | A-Award | A | Restricted Stock Units | 63,400 | 0.00 | — | 63,400 | D | ↗ |
| 2025-01-27 | Garg Vipin K | Director / Officer | A-Award | A | Restricted Stock Units | 164,800 | 0.00 | — | 164,800 | D | ↗ |
| 2025-01-25 | Roberts M Scot | Officer | M-Exempt | A | Restricted Stock Units | 14,600 | 0.00 | — | 43,800 | D | ↗ |
| 2025-01-25 | Jordt Raymond M | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,862 | 6.98 | 27.0K | 32,288 | D | ↗ |
| 2025-01-25 | Harris Matthew Scott | Officer | F-InKind | D | Common Stock, par value $0.0001 | 4,994 | 6.98 | 34.9K | 64,725 | D | ↗ |
| 2025-01-25 | Garg Vipin K | Director / Officer | M-Exempt | A | Restricted Stock Units | 42,050 | 0.00 | — | 126,150 | D | ↗ |
| 2025-01-01 | Jordt Raymond M | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 9,375 | 0.00 | — | 24,035 | D | ↗ |
| 2024-11-11 | WEAVER GREGORY L | Officer | A-Award | A | Stock Options (option to buy) | 225,000 | 7.35 | 1.65M | 225,000 | D | ↗ |
| 2024-09-26 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | Schafer Klaus | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | SAYARE MITCHEL | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | Pisano Wayne | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | Jorkasky Diane | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | Hodges Philip | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-09-26 | GILL JOHN | Director | A-Award | A | Stock Options (option to buy) | 34,900 | 6.81 | 237.7K | 34,900 | D | ↗ |
| 2024-08-19 | Drutz David | Director | M-Exempt | A | Common Stock, par value $0.0001 | 21,750 | 2.50 | 54.4K | 63,708 | — | ↗ |
| 2024-07-31 | Shutterly Andrew | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,259 | 5.41 | 6.8K | 11,372 | — | ↗ |
| 2024-07-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 650 | 5.41 | 3.5K | 43,310 | — | ↗ |
| 2024-07-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 917 | 5.41 | 5.0K | 14,660 | — | ↗ |
| 2024-07-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,486 | 5.41 | 8.0K | 55,119 | — | ↗ |
| 2024-06-26 | Shutterly Andrew | Officer | — | D | Common Stock, par value $0.0001 | 0 | 0.00 | — | 10,113 | — | ↗ |
| 2024-02-02 | Roberts M Scot | Officer | M-Exempt | D | Restricted Stock Units | 7,775 | 0.00 | — | 15,550 | — | ↗ |
| 2024-02-02 | Harris Matthew Scott | Officer | M-Exempt | D | Restricted Stock Units | 7,775 | 0.00 | — | 15,550 | — | ↗ |
| 2024-02-02 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 8,376 | 9.32 | 78.1K | 292,028 | — | ↗ |
| 2024-02-01 | Roberts M Scot | Officer | M-Exempt | D | Restricted Stock Units | 6,166 | 0.00 | — | 6,166 | — | ↗ |
| 2024-02-01 | Harris Matthew Scott | Officer | M-Exempt | D | Restricted Stock Units | 6,166 | 0.00 | — | 6,166 | — | ↗ |
| 2024-02-01 | Garg Vipin K | Director / Officer | M-Exempt | D | Restricted Stock Units | 16,545 | 0.00 | — | 16,545 | — | ↗ |
| 2024-01-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 5,860 | 2.69 | 15.8K | 32,850 | — | ↗ |
| 2024-01-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 5,030 | 2.69 | 13.5K | 13,743 | — | ↗ |
| 2024-01-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 3,257 | 2.69 | 8.8K | 43,825 | — | ↗ |
| 2024-01-31 | Garg Vipin K | Director / Officer | A-Award | A | Common Stock, par value $0.0001 | 7,889 | 2.69 | 21.2K | 272,222 | — | ↗ |
| 2024-01-31 | Eisenstadt Richard I | Officer | A-Award | A | Common Stock, par value $0.0001 | 4,621 | 2.69 | 12.4K | 45,012 | — | ↗ |
| 2024-01-30 | Roberts M Scot | Officer | F-InKind | D | Common Stock, par value $0.0001 | 2,709 | 9.80 | 26.5K | 26,990 | — | ↗ |
| 2024-01-30 | Harris Matthew Scott | Officer | M-Exempt | D | Restricted Stock Units | 9,275 | 0.00 | — | 27,825 | — | ↗ |
| 2024-01-30 | Garg Vipin K | Director / Officer | M-Exempt | A | Common Stock, par value $0.0001 | 26,775 | 0.00 | — | 276,030 | — | ↗ |
| 2024-01-30 | Eisenstadt Richard I | Officer | M-Exempt | D | Restricted Stock Units | 9,275 | 0.00 | — | 27,825 | — | ↗ |
| 2024-01-25 | Roberts M Scot | Officer | A-Award | A | Restricted Stock Units | 58,400 | 0.00 | — | 58,400 | — | ↗ |
| 2024-01-25 | Jordt Raymond M | Officer | A-Award | A | Restricted Stock Units | 58,400 | 0.00 | — | 58,400 | — | ↗ |
| 2024-01-25 | Harris Matthew Scott | Officer | A-Award | A | Stock Options (option to buy) | 163,200 | 9.28 | 1.51M | 163,200 | — | ↗ |
| 2024-01-25 | Garg Vipin K | Director / Officer | A-Award | A | Restricted Stock Units | 168,200 | 0.00 | — | 168,200 | — | ↗ |
| 2024-01-25 | Eisenstadt Richard I | Officer | A-Award | A | Restricted Stock Units | 58,400 | 0.00 | — | 58,400 | — | ↗ |
| 2024-01-01 | Jordt Raymond M | Officer | M-Exempt | D | Restricted Stock Units | 9,375 | 0.00 | — | 28,125 | — | ↗ |
| 2023-12-29 | Eisenstadt Richard I | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 12,500 | 0.00 | — | 36,335 | — | ↗ |
| 2023-09-28 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | Schafer Klaus | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | SAYARE MITCHEL | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | Pisano Wayne | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | Jorkasky Diane | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | Hodges Philip | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | GILL JOHN | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-09-28 | Drutz David | Director | A-Award | A | Stock Options (option to buy) | 26,100 | 2.50 | 65.3K | 26,100 | — | ↗ |
| 2023-08-15 | Drutz David | Director | P-Purchase | A | Common Stock, par value $0.0001 | 300 | 2.88 | 862.50 | 29,785 | — | ↗ |
| 2023-07-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 568 | 2.81 | 1.6K | 20,424 | — | ↗ |
| 2023-07-31 | Jordt Raymond M | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,832 | 2.81 | 5.1K | 1,832 | — | ↗ |
| 2023-07-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 691 | 2.81 | 1.9K | 34,002 | — | ↗ |
| 2023-07-31 | Garg Vipin K | Director / Officer | A-Award | A | Common Stock, par value $0.0001 | 126 | 2.81 | 354.06 | 249,255 | — | ↗ |
| 2023-07-31 | Eisenstadt Richard I | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,825 | 2.81 | 5.1K | 23,835 | — | ↗ |
| 2023-03-24 | Eisenstadt Richard I | Officer | P-Purchase | A | Common Stock, par value $0.0001 | 10,000 | 4.31 | 43.1K | 22,010 | — | ↗ |
| 2023-03-23 | Sohn Catherine A. | Director | A-Award | A | Stock Options (option to buy) | 47,000 | 4.19 | 196.9K | 47,000 | — | ↗ |
| 2023-03-23 | Harris Matthew Scott | Officer | P-Purchase | A | Common Stock, par value $0.0001 | 10,000 | 4.22 | 42.2K | 33,311 | — | ↗ |
| 2023-03-23 | Drutz David | Director | P-Purchase | A | Common Stock, par value $0.0001 | 9,000 | 4.27 | 38.4K | 29,484 | — | ↗ |
| 2023-02-02 | Roberts M Scot | Officer | F-InKind | D | Common Stock, par value $0.0001 | 2,375 | 15.04 | 35.7K | 19,856 | — | ↗ |
| 2023-02-02 | Harris Matthew Scott | Officer | F-InKind | D | Common Stock, par value $0.0001 | 2,364 | 15.04 | 35.6K | 23,311 | — | ↗ |
| 2023-02-02 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 8,422 | 15.04 | 126.7K | 249,129 | — | ↗ |
| 2023-02-01 | Roberts M Scot | Officer | M-Exempt | D | Restricted Stock Units | 6,166 | 0.00 | — | 12,332 | — | ↗ |
| 2023-02-01 | Harris Matthew Scott | Officer | M-Exempt | D | Restricted Stock Units | 6,166 | 0.00 | — | 12,332 | — | ↗ |
| 2023-02-01 | Garg Vipin K | Director / Officer | M-Exempt | D | Restricted Stock Units | 16,546 | 0.00 | — | 33,090 | — | ↗ |
| 2023-01-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,436 | 10.21 | 14.7K | 10,473 | — | ↗ |
| 2023-01-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,296 | 10.21 | 13.2K | 13,917 | — | ↗ |
| 2023-01-31 | Garg Vipin K | Director / Officer | A-Award | A | Common Stock, par value $0.0001 | 1,938 | 10.21 | 19.8K | 229,713 | — | ↗ |
| 2023-01-31 | Eisenstadt Richard I | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,172 | 10.21 | 12.0K | 12,010 | — | ↗ |
| 2023-01-30 | Roberts M Scot | Officer | A-Award | A | Restricted Stock Units | 37,100 | 0.00 | — | 37,100 | — | ↗ |
| 2023-01-30 | Harris Matthew Scott | Officer | A-Award | A | Restricted Stock Units | 37,100 | 0.00 | — | 37,100 | — | ↗ |
| 2023-01-30 | Garg Vipin K | Director / Officer | A-Award | A | Restricted Stock Units | 107,100 | 0.00 | — | 107,100 | — | ↗ |
| 2023-01-30 | Eisenstadt Richard I | Officer | A-Award | A | Restricted Stock Units | 37,100 | 0.00 | — | 37,100 | — | ↗ |
| 2023-01-03 | Jordt Raymond M | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Eisenstadt Richard I | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 12,500 | 0.00 | — | 13,866 | — | ↗ |
| 2022-12-22 | Pisano Wayne | Director | M-Exempt | A | Common Stock, par value $0.0001 | 20,000 | 2.60 | 52.0K | 28,498 | — | ↗ |
| 2022-11-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 9.95 | 29.9K | 227,775 | — | ↗ |
| 2022-11-18 | Drutz David | Director | M-Exempt | A | Common Stock, par value $0.0001 | 139 | 2.40 | 333.60 | 20,151 | — | ↗ |
| 2022-10-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 12.77 | 38.4K | 230,782 | — | ↗ |
| 2022-09-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,008 | 12.77 | 38.4K | 233,789 | — | ↗ |
| 2022-09-29 | Schafer Klaus | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | SAYARE MITCHEL | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | Pisano Wayne | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | Jorkasky Diane | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | Hodges Philip | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | GILL JOHN | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-09-29 | Drutz David | Director | A-Award | A | Stock Options (option to buy) | 23,500 | 0.00 | — | 23,500 | — | ↗ |
| 2022-08-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 18.94 | 57.0K | 256,797 | — | ↗ |
| 2022-08-12 | Garg Vipin K | Officer | S-Sale | D | Common Stock, par value $0.0001 | 15,000 | 15.06 | 225.9K | 259,804 | — | ↗ |
| 2022-08-12 | GILL JOHN | Director | S-Sale | D | Common Stock, par value $0.0001 | 2,714 | 15.00 | 40.7K | 2,771 | — | ↗ |
| 2022-07-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 732 | 6.86 | 5.0K | 9,037 | — | ↗ |
| 2022-07-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,076 | 6.86 | 7.4K | 12,621 | — | ↗ |
| 2022-07-31 | Eisenstadt Richard I | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,366 | 6.86 | 9.4K | 1,366 | — | ↗ |
| 2022-07-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 12.01 | 36.1K | 274,804 | — | ↗ |
| 2022-07-01 | Roberts M Scot | Officer | M-Exempt | D | Stock Options (option to buy) | 787 | 0.00 | — | 14,250 | — | ↗ |
| 2022-06-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 11.70 | 35.2K | 277,811 | — | ↗ |
| 2022-06-29 | Roberts M Scot | Officer | S-Sale | D | Common Stock, par value $0.0001 | 5,462 | 12.00 | 65.5K | 17,700 | — | ↗ |
| 2022-06-27 | Roberts M Scot | Officer | S-Sale | D | Common Stock, par value $0.0001 | 37,352 | 12.00 | 448.3K | 17,700 | — | ↗ |
| 2022-06-27 | Jorkasky Diane | Director | M-Exempt | D | Stock Options (option to buy) | 17,610 | 0.00 | — | 22,390 | — | ↗ |
| 2022-06-20 | Schafer Klaus | Director | M-Exempt | D | Stock Options (option to buy) | 60 | 0.00 | — | 0 | — | ↗ |
| 2022-06-15 | Drutz David | Director | P-Purchase | A | Common Stock, par value $0.0001 | 1,000 | 8.00 | 8.0K | 20,012 | — | ↗ |
| 2022-05-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,008 | 5.03 | 15.1K | 280,818 | — | ↗ |
| 2022-05-24 | Drutz David | Director | P-Purchase | A | Common Stock, par value $0.0001 | 1,200 | 4.50 | 5.4K | 19,012 | — | ↗ |
| 2022-04-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,008 | 4.52 | 13.6K | 283,826 | — | ↗ |
| 2022-03-30 | Garg Vipin K | Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 6.05 | 18.2K | 286,834 | — | ↗ |
| 2022-02-28 | Harris Matthew Scott | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 30,000 | 1.92 | 57.6K | 41,545 | — | ↗ |
| 2022-02-28 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 7.41 | 22.3K | 289,841 | — | ↗ |
| 2022-02-02 | Roberts M Scot | Officer | A-Award | A | Stock Options (option to buy) | 91,600 | 7.53 | 689.7K | 91,600 | — | ↗ |
| 2022-02-02 | Harris Matthew Scott | Officer | A-Award | A | Stock Options (option to buy) | 91,600 | 7.53 | 689.7K | 91,600 | — | ↗ |
| 2022-02-02 | Garg Vipin K | Director / Officer | A-Award | A | Restricted Stock Units | 75,800 | 0.00 | — | 75,800 | — | ↗ |
| 2022-02-01 | Roberts M Scot | Officer | M-Exempt | A | Common Stock, par value $0.0001 | 6,166 | 0.00 | — | 19,883 | — | ↗ |
| 2022-02-01 | Harris Matthew Scott | Officer | M-Exempt | D | Restricted Stock Units | 6,166 | 0.00 | — | 18,498 | — | ↗ |
| 2022-02-01 | Garg Vipin K | Director / Officer | M-Exempt | A | Common Stock, par value $0.0001 | 16,545 | 0.00 | — | 300,503 | — | ↗ |
| 2022-01-31 | Roberts M Scot | Officer | A-Award | A | Common Stock, par value $0.0001 | 2,106 | 6.86 | 14.4K | 13,717 | — | ↗ |
| 2022-01-31 | Harris Matthew Scott | Officer | A-Award | A | Common Stock, par value $0.0001 | 1,800 | 6.86 | 12.3K | 7,562 | — | ↗ |
| 2022-01-31 | Garg Vipin K | Director / Officer | A-Award | A | Common Stock, par value $0.0001 | 2,757 | 6.86 | 18.9K | 283,958 | — | ↗ |
| 2022-01-30 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 2,355 | 7.20 | 17.0K | 281,201 | — | ↗ |
| 2022-01-25 | Drutz David | Director | M-Exempt | D | Stock Options (option to buy) | 70 | 2.40 | 168.00 | 69 | — | ↗ |
| 2022-01-06 | GILL JOHN | Director | G-Gift | D | Common Stock, par value $0.0001 | 2,714 | 0.00 | — | 0 | D | ↗ |
| 2021-12-31 | GILL JOHN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Eisenstadt Richard I | Officer | A-Award | A | Restricted Stock Units | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2021-12-30 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 8.93 | 26.9K | 283,556 | — | ↗ |
| 2021-12-14 | Drutz David | Director | M-Exempt | A | Common Stock, par value $0.0001 | 139 | 2.40 | 333.60 | 17,812 | — | ↗ |
| 2021-11-30 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 10.49 | 31.5K | 286,563 | — | ↗ |
| 2021-11-19 | Drutz David | Director | M-Exempt | A | Common Stock, par value $0.0001 | 70 | 2.40 | 168.00 | 17,673 | — | ↗ |
| 2021-10-30 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 10.80 | 32.5K | 289,570 | — | ↗ |
| 2021-09-30 | Garg Vipin K | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 | 3,007 | 11.31 | 34.0K | 292,577 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-16.0K
Shares Outstanding
88.26M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Vipin K. Garg, Ph.D. Chief Executive Officer | 658.7K | 1.0K | 1.15M | 4.81M | 357.8K | 1.04M | 8.03M | 74.33% | ↗ |
| 2 | 2025 | M. Scott Harris, M.D. former Chief Medical Officer | 388.4K | 1.0K | 443.8K | 1.37M | 204.6K | 219.6K | 2.63M | 69.08% | ↗ |
| 3 | 2025 | Christophe Arbet-Engels, M.D., Ph.D. | 128.8K | 176.0K | 580.5K | 1.39M | 50.9K | 5.8K | 2.33M | 84.49% | ↗ |
| 4 | 2025 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 487.3K | 1.0K | 443.8K | 1.06M | 192.5K | 2.4K | 2.18M | 68.70% | ↗ |
| 5 | 2024 | Vipin K. Garg, Ph.D. Chief Executive Officer | 633.4K | — | 1.56M | 3.54M | 330.9K | 28.7K | 6.09M | 83.70% | ↗ |
| 6 | 2024 | M. Scott Harris, M.D Chief Medical Officer | 498.0K | — | 542.0K | 1.23M | 189.2K | 3.6K | 2.46M | 71.93% | ↗ |
| 7 | 2024 | M. Scott Harris, M.D. former Chief Medical Officer | 498.0K | — | 542.0K | 1.23M | 189.2K | 3.6K | 2.46M | 71.93% | ↗ |
| 8 | 2024 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 468.6K | — | 542.0K | 1.23M | 178.1K | 2.3K | 2.42M | 73.17% | ↗ |
| 9 | 2024 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 468.6K | — | 542.0K | 1.23M | 178.1K | 2.3K | 2.42M | 73.17% | ↗ |
| 10 | 2023 | Vipin K. Garg, Ph.D. Chief Executive Officer | 620.2K | — | 1.38M | 3.12M | 335.0K | 31.0K | 5.48M | 82.01% | ↗ |
| 11 | 2023 | Raymond M. Jordt, M.B.A. Chief Business Officer | 405.0K | — | 586.1K | 1.78M | 162.0K | 11.9K | 2.94M | 80.32% | ↗ |
| 12 | 2023 | M. Scott Harris, M.D Chief Medical Officer | 487.6K | — | 477.8K | 1.08M | 191.5K | 2.7K | 2.24M | 69.56% | ↗ |
| 13 | 2022 | Vipin K. Garg, Ph.D. Chief Executive Officer | 580.0K | — | 570.8K | 1.39M | 319.0K | 17.2K | 2.88M | 68.19% | ↗ |
| 14 | 2022 | M. Scott Harris, M.D Chief Medical Officer | 456.0K | — | 234.2K | 572.4K | 182.4K | 4.6K | 1.45M | 55.64% | ↗ |
| 15 | 2022 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 425.0K | — | 234.2K | 572.4K | 170.0K | 4.3K | 1.41M | 57.37% | ↗ |
| 16 | 2022 | Richard Eisenstadt, M.B.A. Chief Financial Officer | 426.6K | — | — | — | 170.0K | 23.1K | 619.7K | 0.00% | ↗ |
| 17 | 2022 | Raymond M. Jordt, M.B.A. Chief Business Officer | — | — | — | — | — | — | — | — | ↗ |
| 18 | 2021 | Vipin K. Garg, Ph.D. Chief Executive Officer | 565.7K | — | 436.1K | 1.33M | 290.0K | 13.8K | 2.63M | 66.96% | ↗ |
| 19 | 2021 | M. Scott Harris, M.D Chief Medical Officer | 444.4K | — | 412.1K | 1.24M | 165.7K | 4.0K | 2.26M | 72.87% | ↗ |
| 20 | 2021 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 406.0K | — | 412.1K | 1.24M | 154.3K | 4.6K | 2.21M | 74.49% | ↗ |
| 21 | 2021 | William M. Brown, CPA Former Chief Financial Officer | 425.1K | — | 412.1K | 1.24M | — | 14.0K | 2.09M | 78.97% | ↗ |
| 22 | 2021 | Richard Eisenstadt, M.B.A. Chief Financial Officer | — | — | 458.0K | 1.14M | 120.0K | — | 1.72M | 93.00% | ↗ |
| 23 | 2020 | Vipin K. Garg, Ph.D. Chief Executive Officer | 514.4K | — | — | 536.7K | 354.1K | 29.3K | 1.43M | 37.42% | ↗ |
| 24 | 2020 | M. Scott Harris, M.D. Chief Medical Officer | 377.1K | — | — | 93.0K | 188.7K | 11.4K | 670.2K | 13.88% | ↗ |
| 25 | 2020 | M. Scott Harris, M.D Chief Medical Officer | 377.1K | — | — | 93.0K | 188.7K | 11.4K | 670.2K | 13.88% | ↗ |
| 26 | 2020 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 348.6K | — | — | 93.0K | 175.0K | 11.4K | 628.0K | 14.81% | ↗ |
| 27 | 2020 | William M. Brown, CPA Chief Financial Officer | 339.5K | — | — | 93.0K | 170.0K | 19.7K | 622.1K | 14.95% | ↗ |
| 28 | 2020 | William M. Brown, CPA Former Chief Financial Officer | 339.5K | — | — | 93.0K | 170.0K | 19.7K | 622.1K | 14.95% | ↗ |
| 29 | 2020 | Sybil Tasker, M.D., MPH Former Chief Medical Officer | — | — | — | — | — | — | — | — | ↗ |
| 30 | 2020 | Richard Eisenstadt, M.B.A. Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 31 | 2019 | Vipin K. Garg, Ph.D. Chief Executive Officer | 500.0K | — | — | — | 248.0K | 66.6K | 814.6K | 0.00% | ↗ |
| 32 | 2019 | William M. Brown, CPA Chief Financial Officer | 192.5K | — | — | 151.6K | 89.6K | 190.7K | 624.3K | 24.28% | ↗ |
| 33 | 2019 | M. Scot Roberts, Ph.D. Chief Scientific Officer | 316.0K | — | — | 85.6K | 33.8K | 12.8K | 448.3K | 19.10% | ↗ |
| 34 | 2019 | M. Scott Harris, M.D. Chief Medical Officer | 115.0K | — | — | 171.3K | 95.3K | 1.2K | 382.9K | 44.74% | ↗ |
| 35 | 2019 | Sybil Tasker, M.D., MPH Former Chief Medical Officer | 203.5K | — | — | 146.1K | — | 6.9K | 356.5K | 40.98% | ↗ |
| 36 | 2016 | John M. Gill Former President and CEO | 300.0K | — | 1.10M | 135.0K | 150.0K | 8.0K | 1.69M | 72.93% | ↗ |
| 37 | 2016 | Philip MacNeill CFO, Former Treasurer and Secretary | 258.6K | — | — | — | 90.5K | 6.1K | 355.2K | 0.00% | ↗ |
| 38 | 2015 | Eric I. Richman President and CEO | 98.0K | — | — | — | 57.1K | 515.3K | 670.5K | 0.00% | ↗ |
| 39 | 2015 | Philip MacNeill CFO, Former Treasurer and Secretary | 223.9K | — | 84.3K | 73.1K | 87.6K | 6.1K | 475.0K | 33.13% | ↗ |
| 40 | 2015 | Philip MacNeill CFO, Former Treasurer and Secretary | 223.9K | — | 84.3K | 73.1K | 87.6K | 6.1K | 475.0K | 33.13% | ↗ |
| 41 | 2015 | Linda Chang Senior Vice President, CFO and Secretary | 113.6K | — | — | — | — | 275.6K | 389.1K | 0.00% | ↗ |
| 42 | 2015 | John M. Gill Former President and CEO | 159.9K | — | — | — | 175.0K | 1.0K | 335.9K | 0.00% | ↗ |
| 43 | 2015 | John M. Gill Former President and CEO | 159.9K | — | — | — | 175.0K | 1.0K | 335.9K | 0.00% | ↗ |
| 44 | 2015 | Francesca Cook Senior Vice President, Policy and Government Affairs | 59.6K | — | — | — | — | 162.6K | 222.1K | 0.00% | ↗ |
| 45 | 2015 | Jeffrey M. Jones, PhD. | 157.2K | — | — | — | — | 11.6K | 168.8K | 0.00% | ↗ |
| 46 | 2014 | Eric I. Richman President and CEO | 496.5K | — | — | 332.4K | 186.2K | 6.2K | 1.02M | 32.55% | ↗ |
| 47 | 2014 | Eric I. Richman President and CEO | 496.5K | — | — | 332.4K | 186.2K | 6.2K | 1.02M | 32.55% | ↗ |
| 48 | 2014 | Linda Chang Senior Vice President, CFO and Secretary | 340.7K | — | — | 228.4K | 79.2K | 8.8K | 657.1K | 34.76% | ↗ |
| 49 | 2014 | Linda L. Chang Senior Vice President, CFO and Secretary | 340.7K | — | — | 228.4K | 79.2K | 8.8K | 657.1K | 34.76% | ↗ |
| 50 | 2014 | Francesca Cook Senior Vice President, Policy and Government Affairs | 314.0K | — | — | 210.5K | 50.4K | 8.4K | 583.2K | 36.09% | ↗ |
| 51 | 2014 | Francesca Cook Senior Vice President, Policy and Gov’t Affairs | 314.0K | — | — | 210.5K | 50.4K | 8.4K | 583.2K | 36.09% | ↗ |
| 52 | 2014 | Wayne Morges, Ph.D. Senior Vice President, Regulatory Affairs and Quality | 305.8K | — | — | 205.0K | 49.1K | 8.8K | 568.6K | 36.05% | ↗ |
| 53 | 2014 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | 26.7K | — | — | — | — | 162.0K | 188.7K | 0.00% | ↗ |
| 54 | 2013 | Eric I. Richman President and CEO | 456.2K | — | — | 455.6K | 68.4K | 5.8K | 986.0K | 46.21% | ↗ |
| 55 | 2013 | Eric I. Richman President and CEO | 456.2K | — | — | — | 68.4K | 5.8K | 986.0K | 0.00% | ↗ |
| 56 | 2013 | Eric I. Richman President and Chief Executive Officer, Director | 456.2K | — | — | 455.6K | 68.4K | — | 980.2K | 46.48% | ↗ |
| 57 | 2013 | Linda L. Chang Senior Vice President, CFO and Secretary | 318.0K | — | — | 299.0K | 58.2K | 12.4K | 687.6K | 43.48% | ↗ |
| 58 | 2013 | Linda Chang Senior Vice President, CFO and Secretary | 318.0K | — | — | 299.0K | 58.2K | 12.4K | 687.1K | 43.51% | ↗ |
| 59 | 2013 | Linda L. Chang Senior Vice President, Chief Financial Officer and Corporate Secretary | 318.0K | — | — | 299.0K | 58.2K | 9.0K | 684.2K | 43.70% | ↗ |
| 60 | 2013 | Wayne Morges, Ph.D. Senior Vice President, Regulatory Affairs and Quality | 286.4K | 40.0K | — | 270.5K | 35.9K | 16.3K | 649.2K | 41.67% | ↗ |
| 61 | 2013 | Francesca Cook Senior Vice President, Policy and Government Affairs | 294.4K | — | — | 277.6K | 36.9K | 16.4K | 625.3K | 44.40% | ↗ |
| 62 | 2013 | Francesca Cook Senior Vice President, Policy and Gov’t Affairs | 294.4K | — | — | 277.6K | 36.9K | 16.4K | 625.3K | 44.40% | ↗ |
| 63 | 2013 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | 320.6K | 20.0K | — | — | 40.2K | 16.4K | 397.2K | 0.00% | ↗ |
| 64 | 2012 | Eric I. Richman President and Chief Executive Officer, Director | 442.9K | 146.2K | — | 129.9K | — | — | 719.0K | 18.07% | ↗ |
| 65 | 2012 | Eric . Richman President and Chief Executive Officer, Director | 442.9K | 146.2K | — | 129.9K | — | — | 719.0K | 18.07% | ↗ |
| 66 | 2012 | Eric I. Richman President and CEO | 442.9K | 146.2K | — | 129.9K | — | — | 719.0K | 18.07% | ↗ |
| 67 | 2012 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | 309.0K | 67.7K | — | 53.5K | — | 12.0K | 442.1K | 12.09% | ↗ |
| 68 | 2012 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | 309.0K | 67.7K | — | 53.5K | — | 12.0K | 442.1K | 12.09% | ↗ |
| 69 | 2012 | Thomas R. Fuerst, Ph.D. Executive Vice President, Chief, Scientific Officer | 257.9K | — | — | — | — | 178.4K | 436.4K | 0.00% | ↗ |
| 70 | 2012 | Linda L. Chang Senior Vice President, CFO and Secretary | 300.0K | 71.1K | — | 61.7K | — | — | 432.8K | 14.26% | ↗ |
| 71 | 2012 | Linda L. Chang Senior Vice President, Chief Financial Officer and Corporate Secretary | 300.0K | 71.1K | — | 61.7K | — | — | 432.8K | 14.26% | ↗ |
| 72 | 2012 | Francesca Cook Senior Vice President, Policy and Gov’t Affairs | 283.1K | 67.1K | — | 53.5K | — | 12.0K | 415.6K | 12.86% | ↗ |
| 73 | 2012 | Francesca Cook | 283.1K | 67.1K | — | 53.5K | — | 12.0K | 415.6K | 12.86% | ↗ |
| 74 | 2011 | Eric I. Richman President and Chief Executive Officer, Director | 435.0K | 93.6K | 131.0K | 225.3K | — | — | 884.9K | 40.27% | ↗ |
| 75 | 2011 | Eric I. Richman President and Chief Executive Officer, Director | 435.0K | 93.6K | 131.0K | 225.3K | — | — | 884.9K | 40.27% | ↗ |
| 76 | 2011 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | 300.0K | 44.3K | 44.0K | 124.8K | — | 12.0K | 525.1K | 32.15% | ↗ |
| 77 | 2011 | Thomas R. Fuerst, Ph.D. Executive Vice President, Chief, Scientific Officer | 313.6K | 35.5K | — | 88.9K | — | 24.0K | 462.0K | 19.24% | ↗ |
| 78 | 2011 | Jordan P. Karp, Esq. Senior Vice President and General Counsel | — | — | — | 124.8K | — | — | — | — | ↗ |
| 79 | 2010 | Eric I. Richman President and Chief Executive Officer, Director | 334.4K | — | 136.9K | 1.56M | 105.0K | 9.0K | 2.15M | 79.13% | ↗ |
| 80 | 2010 | Thomas R. Fuerst, Ph.D. Executive Vice President, Chief, Scientific Officer | 226.6K | 65.0K | — | — | 17.7K | 17.8K | 989.0K | 0.00% | ↗ |
| 81 | 2010 | Thomas R. Fuerst, Ph.D. Executive Vice President, Chief, Scientific Officer | 226.6K | 65.0K | — | 661.9K | 17.7K | 17.8K | 989.0K | 66.93% | ↗ |
| 82 | 2010 | Charles A. Reinhart III | 330.0K | — | — | 248.8K | 29.7K | 42.4K | 650.9K | 38.22% | ↗ |
| 83 | 2010 | David P. Wright Former Chief Executive Officer, Former Director | 142.0K | — | — | — | — | 239.7K | 381.7K | 0.00% | ↗ |
| 84 | 2009 | David P. Wright Chief Executive Officer, Director | 426.4K | — | 91.5K | 67.5K | — | 15.3K | 600.8K | 26.47% | ↗ |
| 85 | 2009 | David P. Wright Former Chief Executive Officer, Former Director | 426.4K | — | 91.5K | 67.5K | — | 15.3K | 600.8K | 26.47% | ↗ |
| 86 | 2009 | Wayne Morges, Ph.D. Vice President, Regulatory Affairs and Quality | 260.2K | — | 63.0K | 163.5K | — | 9.8K | 496.4K | 45.61% | ↗ |
| 87 | 2009 | Eric I. Richman President and Chief Executive Officer, Director | 287.8K | — | 75.2K | 55.5K | — | 8.5K | 427.0K | 30.62% | ↗ |
| 88 | 2009 | Eric I. Richman President and interim Chief Executive Officer | 287.8K | — | 75.2K | 55.5K | — | 8.5K | 427.0K | 30.62% | ↗ |
| 89 | 2008 | David P. Wright Chief Executive Officer | 407.7K | — | 131.7K | — | 37.9K | 13.2K | 1.43M | 9.19% | ↗ |
| 90 | 2008 | Eric I. Richman Senior Vice President, | 275.1K | — | 52.0K | — | 31.2K | 8.0K | 603.2K | 8.62% | ↗ |
| 91 | 2008 | Christopher C. Camut | 247.0K | — | 41.6K | 215.6K | 25.8K | 7.9K | 537.9K | 47.82% | ↗ |
| 92 | 2008 | David P. Wright Chief Executive Officer, Director | 407.7K | — | — | — | 37.9K | 13.2K | 458.8K | 0.00% | ↗ |
| 93 | 2008 | Eric I. Richman President and interim Chief Executive Officer | 275.1K | — | — | — | 31.2K | 8.0K | 314.3K | 0.00% | ↗ |
| 94 | 2008 | Wayne Morges, Ph.D. Vice President, Regulatory Affairs and Quality | 249.8K | — | — | — | 26.1K | 9.8K | 285.7K | 0.00% | ↗ |
| 95 | 2007 | David P. Wright Chief Executive Officer | 369.2K | 100.0K | 36.1K | — | — | 1.2K | 809.0K | 4.47% | ↗ |
| 96 | 2007 | Eric I. Richman Senior Vice President, | 259.8K | 65.0K | 12.8K | — | — | 270.00 | 552.8K | 2.32% | ↗ |
| 97 | 2006 | David P. Wright, President, Chief Executive Officer and Director | 334.5K | — | — | 9.4K | — | — | 343.9K | 2.73% | ↗ |
| 98 | 2006 | Richard Schoenfeld, Vice President Operations | 236.9K | — | — | — | — | 29.4K | 266.3K | 0.00% | ↗ |
| 99 | 2006 | Ronald Kaiser, Vice President and Chief Financial Officer, (resigned December 4, 2006) | 256.9K | — | — | 1.8K | — | — | 258.7K | 0.71% | ↗ |
| 100 | 2006 | Valerie Riddle, MD, Vice President, Medical Director | 234.0K | — | — | 4.0K | — | — | 238.0K | 1.68% | ↗ |
| 101 | 2006 | Eric I. Richman, Senior Vice President, Business Development and Strategic Planning | 216.9K | — | — | 3.8K | — | — | 220.7K | 1.73% | ↗ |
| 102 | 2006 | Solomon Langermann, Ph.D., Vice President, Chief Scientific Officer | 201.5K | — | — | 3.4K | — | — | 204.9K | 1.65% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Scot Roberts | Chief Scientific Officer | 683.2K | — |
| Gregory L. Weaver | Chief Financial Officer | 619.7K | male |
| Raymond Jordt | Chief Business Officer | 578.9K | male |
| Christophe Arbet-Engels | Chief Medical Officer | 361.4K | — |
| Jerome Benedict Durso | Chairman, CEO & President | 50.9K | male |
| Tony Blandin | Vice President of Quality & Compliance Management | — | male |
| Bertrand Georges | Chief Technology Officer | — | male |
| Linda Richardson | Chief Commercial Officer | — | female |
| Robin E. Abrams | Chief Legal Officer & Corporate Secretary | — | female |
| Andrew Shutterly | Principal Financial & Accounting Officer and Corporate Controller | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
